Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 9, 2007

View Archived Issues

SASP technology: a novel approach to treat bacterial infections

MenACWY-TT meningococcal vaccine immunogenic in children

In vitro studies reveal antibacterial activity of novel carbapenem ME-1036

Sitafloxacin demonstrates efficacy against urinary tract infection pathogens

New antidiabetic agents disclosed in recent patents

Novel antiinfective agents disclosed in recent patent literature

Prexige withdrawn from Canadian market

Lilly advances atomoxetine to phase II for adult ADHD in Japan

Aptivus receives full FDA approval as part of combination therapy for HIV

Genesis to continue to use MorphoSys' HuCAL-based antibodies for drug discovery

GSK seeks prequalification for Cervarix from the WHO

Interim analysis complete in pivotal pafuramidine trial for African sleeping sickness

Phase I study commences for topical diclofenac sodium patch

Top-line results reported for granulated mesalamine in ulcerative colitis

TopoTarget and Lundbeck sign agreement for siramesine

Wyeth acquires biopharmaceutical company Haptogen

Ixabepilone improves progression-free survival in phase III metastatic breast cancer study

HI-164 vaccine reduces hospitalizations in COPD patients

Ki-26894 shows potential for the treatment of gastric cancer in vivo

EpiCept successfully completes phase I with novel small-molecule VDA

Avontec advances AVT-02 UE into the clinic for inflammatory skin diseases

Positive phase IIb data reported for BHT-3009 in multiple sclerosis

Loss of T-bet function leads to a communicable form of ulcerative colitis in mice / News in Context

Positive interim data reported for PRX-302

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...